Drugs / BicaVera
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT03994471 Comparator | Dec 2022 → Dec 2026 expected | end stage renal failure | Iperboreal Pharma Srl | Recruiting | No outcome recorded |
| Phase 4 | NCT01632046 Comparator | Mar 2004 → Mar 2007 | chronic renal failure syndrome | Heidelberg University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BicaVera | “If patient randomised to the BicaVera arm he will be dialysed with bicarbonate based PD fluid (BicaVera) for 10 months.” NCT01632046 ↗1“Balance, Bicavera, Bicanova or Equibalance have 1.25%, 2.3%, 4.5% glucose” NCT03994471 ↗ |